New treatment option for Postoperative Acute Kidney Injury
Official title Processed Electroencephalography-guided General Anesthesia and Outcomes in Major Abdominal Surgery
ClinicalTrials.gov ID: NCT06753409
What this study is testing
- What it's testing
- This study aims to evaluate whether the reduction in the amount of intraoperative norepinephrine required to prevent hypotension, facilitated by processed electroencephalography (pEEG) -guided general anesthesia, will lead to a decrease in postoperative complications, particularly acute kidney injury (AKI).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patients scheduled for major abdominal surgery lasting more than 2 hours under general anesthesia.
- American Society of Anesthesiologists Physical Status (ASA) score I-III.
- Age range of 18-70 years.
- Both male and female patients.
You likely can't join if
- Emergency surgeries.
- Uncontrolled hypertension (systolic blood pressure \>150 mm Hg) despite medication.
- Recent acute cardiovascular events, including heart failure or acute coronary syndrome.
- Chronic kidney disease with a glomerular filtration rate \<30 ml/min/1.73 m² or requiring renal replacement therapy.
- Severe hepatic failure (ASAT/ALAT \>2N, elevated bilirubin, or PT \<50%).
- Preoperative sepsis or septic shock.
See the full eligibility criteria
- Patients scheduled for major abdominal surgery lasting more than 2 hours under general anesthesia.
- American Society of Anesthesiologists Physical Status (ASA) score I-III.
- Age range of 18-70 years.
- Both male and female patients.
- Emergency surgeries.
- Uncontrolled hypertension (systolic blood pressure \>150 mm Hg) despite medication.
- Recent acute cardiovascular events, including heart failure or acute coronary syndrome.
- Chronic kidney disease with a glomerular filtration rate \<30 ml/min/1.73 m² or requiring renal replacement therapy.
- Severe hepatic failure (ASAT/ALAT \>2N, elevated bilirubin, or PT \<50%).
- Preoperative sepsis or septic shock.
- Pregnancy.
- Patient refusal to participate in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.